Life Sciences R&D (LRD) Fund 1, Japan
Year Launched:
2023
Fund Status:
Closed
Assets to Date:
3
GAV:
More than USD 350 Million
Strategy:
Value Add
ECM’s Life Sciences R&D strategy – GRC Properties – invests in high-specification institutional-grade assets that support innovation across life sciences, advanced manufacturing and other research-driven sectors in Japan. The portfolio comprises LRD facilities designed to meet the modern research & development needs of tenants, featuring high-spec spaces and flexible floorplates suitable for both wet and dry laboratory use.
GRC Yokohama Bay Research Park
Yokohama, Japan
A 17 storey R&D and office building in the city of Yokohama spanning over 50,000 square meters of gross floor area.
GRC Yokohama Science Cube
Yokohama, Japan
A station-front R&D and medical building in the city of Yokohama, with over 7,250 square meters of gross floor area.
GRC Shinagawa Innovation Park
Tokyo, Japan
An 18 storey R&D and office building in Tokyo’s Shinagawa district with over 38,000 square meters of gross floor area.
For more information visit:
www.grcproperties.com